Special clinical interest in skin and prostate cancer, Volumetric Modulated Arc Therapy, stereotactic radiotherapy.
Director of Radiation Oncology at the St Vincent’s Clinic, St Vincent’s General Hospital, Darlinghurst, and the Mater Hospital, North Sydney.
In addition to treating patients at GenesisCare St Vincent’s, Prof Fogarty is also on staff at the Mater Hospital, Melanoma Institute of Australia and the Skin & Cancer Foundation Australia in Sydney. He has spearheaded the use of Intensity Modulated Radiotherapy, a modern radiotherapy technique, in those departments. The Mater Sydney is the nation leader in Volumetric Modulated Arc Therapy, an even more conformal means of delivering external beam radiotherapy more safely, rapidly and economically. He also has an interest in prostate cancer and stereotactic body radiotherapy.
He trained at Peter MacCallum Cancer Institute, Australia’s largest cancer centre. He is a recognised authority in the radiation treatment of skin cancer, with a PhD in modern radiation treatments of skin cancer. He has over 100 publications. He has NHMRC funding to over $3 million for an ongoing randomised trial of radiation in melanoma. He is also currently the Master of Warrane College, a university residence at University of NSW, Sydney.
Professor Fogarty has over 100 publications.
- Radiotherapy is associated with significant improvement in local and regional control in Merkel cell carcinoma
- Radiotherapy for lentigo maligna: a literature review and recommendations for treatment
- Definitive Radiotherapy for Basal Cell Carcinoma and Cutaneous Squamous Cell Carcinoma of the Nose
- Volumetric modulated arc therapy (VMAT) for skin field cancerisation of the nose – A technique and case report
- Common dermatology questions and answers about the radiation treatment of skin cancer in the modern era
Prof Fogarty is a recognised authority in the radiation treatment of skin cancer, with a PhD in modern radiation treatments of skin cancer. He has NHMRC funding to over $3 million for an ongoing randomised trial of radiation in melanoma.